Janssen Pharmaceuticals Offers a New Approach to Treating Depression
With spring quickly approaching bringing longer days and more sunlight, it’s important to understand if you’re feeling down because of the change in seasons or if something more serious is going on.
Clinical depression, also known as major depressive disorder (MDD), is one of the most common mental disorders in the United States with nearly one in 10 adults suffering from it. For some individuals, MDD can result in severe impairments that interfere with or limit your ability to carry out major life activities.
Symptoms of MDD may include a depressed mood, loss of interest or pleasure, change in sleep, appetite or weight, diminished concentration, feelings of worthlessness, slowing down of thought and a reduction of movements in an individual, suicidal ideation and/or fatigue or loss of energy.
What’s more – one-third of adults in the U.S. with MDD may have treatment-resistant depression (TRD) – which means they haven’t responded adequately to two or more antidepressant medications during the same depressive episode. However, there are treatment options that can help those experiencing TRD.
Dr. Andrew Cutler, a psychiatrist and Chief Medical Officer at the Neuroscience Education Institute shares the signs and symptoms of challenging-to-treat depression and outline a treatment option to manage depressive symptoms.
Interview courtesy: Janssen Pharmaceuticals, Inc. Learn more at: spravato.com.
THIS ARTICLE INVOLVES COMMERCIAL CONTENT. THE PRODUCTS AND SERVICES FEATURED APPEAR AS PAID ADVERTISING VIA PUBLIC RELATIONS. FOR MORE INFORMATION, EMAIL US AT INFO@FAITHHEALTHANDHOME.COM.